Prasad Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
1,048
+13
+1% +$13.3K 0.3% 55
2026
Q1
$952K Buy
1,035
+2
+0.2% +$2.03K 0.26% 57
2025
Q4
$1.11M Buy
1,033
+5
+0.5% +$4.78K 0.3% 50
2025
Q3
$785K Sell
1,028
-4
-0.4% -$2.98K 0.22% 54
2025
Q2
$805K Buy
1,032
+407
+65% +$316K 0.24% 54
2025
Q1
$516K Hold
625
0.17% 65
2024
Q4
$482K Buy
+625
New +$518K 0.16% 66

Other funds holding LLY

Prasad Wealth Partners's LLY Position: Q2 2026 in Review

Prasad Wealth Partners increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $13.3K and bringing the position to 1,048 shares worth $1.26M. The position accounts for 0.3% of the portfolio, ranked #55.

Prasad Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prasad Wealth Partners held 1,048 shares of Eli Lilly worth $1.26M as of Q2 2026.
  • Prasad Wealth Partners bought 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.3% of Prasad Wealth Partners's portfolio in Q2 2026, its #55 holding.
  • Prasad Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prasad Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.